Article
The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
Clinics in laboratory medicine - 1 Dec 2008
Reynolds Kristen K, Ramey-Hartung Bronwyn, Jortani Saeed A
Abstract excerpt
In managing pain, clinicians working with the more than 80 million people in the United States who suffer annually from serious pain face decisions about choosing the most appropriate pharmacologic agent, to contemplating nonpharmacologic modalities. This article focuses on opioid use for pain management, their risks of toxicity and addiction, adverse reactions, undertreatment for fear of addiction, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.